Bryan Hill

Digital

Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.

News

Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.